leisure time -WSS

leisure time

author：entertainment 2025-09-28 18:39:59 - browse：296

Balance innovation — A federal judge made a key ruling in a lawsuit challenging a new drug pricing program Adobe

WASHINGTON — A federal court judge allowed a new Medicare drug price negotiation program to proceed while the court deliberates whether it is constitutional.

The case centers on Democrats’ new law, which empowered the Medicare program to start negotiating lower prices for certain medicines that are especially expensive for the government. Judge Michael Newman, a Trump appointee to the U.S. District Court for the Southern District of Ohio, ruled against the U.S. Chamber of Commerce, which had sued the federal government and asked for the program to be stopped while litigation continues.

Medicare officials announced the first 10 drugs they would negotiate over last month, and the deadline for the pharmaceutical companies to sign agreements to start bargaining is Oct. 1. The Chamber of Commerce had requested a decision on the preliminary injunction by that date.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Let's speed up science by embracing open access publishing

Wikipedia

WSS

Illumina names Agilent executive as new CEO

Why Novartis is changing the name of its research labs

ASCO Daily Recap: Safety data from Novartis, survival from Pfizer

Illumina names Agilent executive as new CEO

House transparency, PBM reform bill gains bipartisan support

Cord blood banking comes at a high cost to babies

explore

leisure time

hotspot

What does generative AI mean for health care? We asked experts

ASCO: Palliative care found as helpful given virtually as in person

Guidelines to prevent youth baseball injuries need more muscle

What drug price negotiations mean for Medicare Part D

Cancer drug shortages should be causing more outrage

Humana sues Biden admin over Medicare Advantage audit rule

United colonoscopy coverage change 'may cost lives,' doctors say

ASCO 2024: 'Reassuring' Corbus data on ADC bladder cancer drug

Medical records are filled with copy

For one rare type of lung cancer, Pfizer pill reduces progression by 81%

focus

For one rare type of lung cancer, Pfizer pill reduces progression by 81%

Ethical issues complicate the benefits of medical crowdfunding

Woman returns to dialysis after doctors remove transplanted pig kidney

ASCO: AstraZeneca's Tagrisso greatly slowed some lung cancers

A new House health package & hospitals’ new site

See how much Covid

entertainment

explore

Wikipedia

knowledge